HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jochen A Sembill Selected Research
Jochen A Sembill Research Topics
Disease
11
Cerebral Hemorrhage
01/2021 - 01/2018
10
Hematoma
01/2021 - 01/2018
4
Hemorrhage
01/2021 - 01/2019
3
Ischemic Stroke
01/2022 - 01/2020
3
Status Epilepticus (Complex Partial Status Epilepticus)
01/2022 - 03/2018
3
Stroke (Strokes)
01/2022 - 01/2018
2
Seizures (Absence Seizure)
01/2022 - 01/2021
2
Edema (Dropsy)
01/2021 - 01/2019
2
Pneumonia (Pneumonitis)
04/2018 - 01/2017
1
Cognitive Dysfunction
01/2023
1
Dementia (Dementias)
01/2023
1
Alzheimer Disease (Alzheimer's Disease)
01/2023
1
Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
01/2023
1
Traumatic Brain Injuries (Traumatic Brain Injury)
01/2022
1
Infarction (Infarctions)
01/2022
1
Bacterial Meningitis
01/2022
1
Thrombocytopenia (Thrombopenia)
01/2021
1
Heart Failure
08/2020
1
Hypertension (High Blood Pressure)
08/2020
1
Diabetes Mellitus
08/2020
1
Venous Thromboembolism
01/2019
1
Atrial Fibrillation
01/2019
1
Encephalitis (Encephalitis, Rasmussen)
03/2018
1
Sepsis (Septicemia)
01/2017
Drug/Important Bio-Agent (IBA)
7
Anticoagulants
IBA
01/2021 - 01/2018
6
Vitamin K
FDA Link
01/2021 - 01/2018
5
N(4)-oleylcytosine arabinoside
IBA
01/2021 - 01/2018
2
APT
IBA
01/2021 - 11/2018
2
Hemostatics (Antihemorrhagics)
IBA
06/2019 - 01/2018
1
Biomarkers (Surrogate Marker)
IBA
01/2023
1
Hemosiderin
IBA
01/2023
1
Amyloid (Amyloid Fibrils)
IBA
01/2023
1
Amantadine (Aman)
FDA Link
Generic
01/2022
1
Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
IBA
01/2021
1
Anticonvulsants (Antiepileptic Drugs)
IBA
01/2020
1
Rivaroxaban
IBA
06/2019
1
apixaban
IBA
06/2019
1
edoxaban
IBA
06/2019
1
Dabigatran
FDA Link
06/2019
1
Heparin (Liquaemin)
FDA Link
Generic
01/2019
1
Nicotine
FDA Link
04/2018
1
Diazepam (Valium)
FDA Link
Generic
03/2018
1
Factor Xa Inhibitors
IBA
01/2018
1
Tranexamic Acid (AMCA)
FDA Link
01/2018
1
Troponin
IBA
01/2018
1
prothrombin complex concentrates (PPSB)
IBA
01/2018
1
Prothrombin (Factor II)
IBA
01/2018
1
idarucizumab
IBA
01/2018
1
Troponin I
IBA
01/2018
1
PRT064445
IBA
01/2018
1
C-Reactive Protein
IBA
01/2017
Therapy/Procedure
7
Therapeutics
01/2021 - 10/2018
3
Length of Stay
01/2020 - 01/2018
1
Thrombectomy
01/2022
1
Platelet Transfusion (Blood Platelet Transfusions)
01/2021
1
Anticoagulation Reversal
01/2020
1
Conservative Treatment
10/2019